Abstract
Degradation of Favipiravir using a hybrid system of peroxydisulfate, FeMnOx binary metal oxide, and ultrasound irradiation was studied. A novel catalyst was synthesized with deep eutectic solvent (DES). The effects of DES type on catalytic performance was evaluated and the catalysts were characterized using XRD, SEM, BET, XPS, and EDS. DES-based catalysts exhibited higher efficiency due to structure change, surface area enhancement and significantly improved Favipiravir adsorption. The DES-based catalyst exhibited a 30 % increase in surface area and a 20-fold increase in Mn content. Additionally, XRD and XPS analyses suggested the reduction of Fe3+ ions, possibly to Fe3O4. Optimal operational parameters (pH = 10, catalyst dose = 500 mg/L, and rox = 20) provide removal efficiency of 70.1 % after 3 h. The catalyst showed stable activity after three cycles, indicating reusability. This study presents a promising approach for the sustainable degradation of COVID-19 APIs, with implications for the pharmaceutical industry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
